Clinical Trial Update: Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating conditioning with thiotepa, cyclophosphamide, and busulfan before allogeneic hematopoietic stem cell transplantation for NK/T-cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nk T-cell Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: NK T-Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING